IL17A and neurodegenerative disease: Nonetheless, the elevated serum level of IL-17 present in our intracerebrally α-synuclein-infused rats is worthy of note, and is in line with the pivotal role currently attributed to this cytokine in neurodegenerative diseases and in glial cell activation [96].